Insider Selling: Phreesia, Inc. (NYSE:PHR) SVP Sells 2,063 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) SVP David Linetsky sold 2,063 shares of the stock in a transaction that occurred on Thursday, July 17th. The stock was sold at an average price of $26.89, for a total value of $55,474.07. Following the completion of the transaction, the senior vice president directly owned 191,447 shares in the company, valued at approximately $5,148,009.83. This trade represents a 1.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

David Linetsky also recently made the following trade(s):

• On Friday, June 27th, David Linetsky sold 23,729 shares of Phreesia stock. The shares were sold at an average price of $28.50, for a total transaction of $676,276.50.
• On Wednesday, June 18th, David Linetsky sold 67 shares of Phreesia stock. The shares were sold at an average price of $25.61, for a total transaction of $1,715.87.
• On Tuesday, June 17th, David Linetsky sold 42 shares of Phreesia stock. The shares were sold at an average price of $25.17, for a total transaction of $1,057.14.

Phreesia Trading Up 4.0%

Shares of Phreesia stock traded up $1.03 during midday trading on Monday, reaching $26.51. 597,110 shares of the company's stock traded hands, compared to its average volume of 456,444. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The company has a market cap of $1.58 billion, a PE ratio of -35.82 and a beta of 0.72. The stock has a 50 day moving average of $26.50 and a 200-day moving average of $26.41. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95.

Phreesia (NYSE:PHR - Get Free Report) last announced its earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The firm had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. During the same quarter in the previous year, the business earned ($0.05) EPS. The company's quarterly revenue was up 14.5% on a year-over-year basis. As a group, equities analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Deutsche Bank AG raised its stake in shares of Phreesia by 95.9% during the 4th quarter. Deutsche Bank AG now owns 57,297 shares of the company's stock worth $1,442,000 after buying an additional 28,047 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of Phreesia by 23.2% during the first quarter. Bessemer Group Inc. now owns 47,758 shares of the company's stock worth $1,222,000 after buying an additional 8,978 shares during the period. SG Americas Securities LLC acquired a new position in shares of Phreesia during the first quarter worth approximately $462,000. Raymond James Financial Inc. acquired a new stake in Phreesia in the fourth quarter worth approximately $379,000. Finally, Barclays PLC increased its holdings in shares of Phreesia by 120.4% in the fourth quarter. Barclays PLC now owns 209,209 shares of the company's stock valued at $5,264,000 after buying an additional 114,280 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on PHR shares. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Citigroup restated a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. DA Davidson decreased their price objective on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Truist Financial boosted their price objective on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Finally, KeyCorp upped their price target on shares of Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has an average rating of "Buy" and a consensus target price of $32.27.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.